WELLINGTON MANAGEMENT GROUP LLP – Vertex Pharmaceuticals Incorporated Transaction History
WELLINGTON MANAGEMENT GROUP LLP portfolio value:
$2.32B
portfolio value
WELLINGTON MANAGEMENT GROUP LLP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.50% | -206.29K shares | 4.09M | $289.54 | 8.02M |
| Q2 2022 | share | Increase | +2.26% | 181.92K shares | 218.94M | $281.79 | 8.23M |
| Q1 2022 | share | Increase | +23.55% | 1.53M shares | 670.32M | $260.97 | 8.05M |
| Q4 2021 | share | Increase | +7.02% | 427.36K shares | 326.59M | $222.45 | 6.51M |
| Q3 2021 | share | Decrease | -26.58% | -2.20M shares | -567.79M | $181.39 | 6.09M |
| Q2 2021 | share | Increase | +2.59% | 209.32K shares | -65.02M | $201.63 | 8.29M |
| Q1 2021 | share | Decrease | -12.17% | -1.12M shares | -438.18M | $214.89 | 8.08M |
| Q4 2020 | share | Increase | +48.82% | 3.02M shares | 492.40M | $236.34 | 9.20M |
| Q3 2020 | share | Decrease | -4.26% | -275.34K shares | -192.46M | $272.12 | 6.18M |
| Q2 2020 | share | Decrease | -15.11% | -1.14M shares | 64.70M | $290.31 | 6.46M |
| Q1 2020 | share | Increase | +2.36% | 175.60K shares | 183.07M | $237.95 | 7.61M |
| Q4 2019 | share | Decrease | -9.79% | -807.38K shares | 231.52M | $218.95 | 7.43M |
| Q3 2019 | share | Decrease | -0.18% | -15.06K shares | -117.84M | $169.42 | 8.24M |
| Q2 2019 | share | Decrease | -6.46% | -570.17K shares | -109.59M | $183.38 | 8.25M |
| Q1 2019 | share | Increase | +2.44% | 210.38K shares | 195.9M | $183.95 | 8.82M |
| Q4 2018 | share | Decrease | -9.34% | -887.38K shares | -403.98M | $165.71 | 8.61M |
| Q3 2018 | share | Decrease | -7.79% | -802.61K shares | 80.13M | $192.74 | 9.50M |
| Q2 2018 | share | Decrease | -6.93% | -767.10K shares | -53.07M | $169.96 | 10.30M |
| Q1 2018 | share | Decrease | -10.57% | -1.30M shares | -50.81M | $162.98 | 11.07M |
| Q4 2017 | share | Decrease | -6.66% | -883.15K shares | -161.27M | $149.86 | 12.38M |
| Q3 2017 | share | Decrease | -16.39% | -2.60M shares | -27.76M | $152.04 | 13.26M |
| Q2 2017 | share | Decrease | -10.68% | -1.89M shares | 102.23M | $128.87 | 15.86M |
| Q2 2017 | call | Decrease | -100.00% | -100 shares | -280K | $128.87 | 0 |
| Q1 2017 | share | Increase | +19.07% | 2.84M shares | 843.53M | $109.35 | 17.76M |
| Q1 2017 | call | Increase | 0.00% | 100 shares | 280K | $109.35 | 100 |
| Q4 2016 | share | Increase | +3.44% | 496.31K shares | -158.73M | $73.67 | 14.92M |
| Q3 2016 | share | Increase | +2.39% | 336.19K shares | 46.08M | $87.21 | 14.42M |
| Q2 2016 | share | Decrease | -4.34% | -639.52K shares | 41.15M | $86.02 | 14.08M |
| Q1 2016 | share | Decrease | -0.92% | -136.81K shares | -699.67M | $79.49 | 14.72M |